Becker B, et al. - Experts attempted to discern the 12-month outcomes of low-powered holmium laser enucleation of the prostate (LP-HoLEP) for patients with symptomatic benign prostatic obstruction (BPO). They illustrated that LP-HoLEP was technically feasible, safe and effective for the treatment of symptomatic BPO. Moreover, power was found to be less relevant than technique, for experienced surgeons.